Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future.

Med Res Rev · 2025 · PMC11638809 · PMID 39139038

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

a nonsignificant trendp = 0.12not close (p > 0.1)

29 , 30 Notably, this appeared to be driven by fewer cases of stroke (HR: 0.61, 95% CI: 0.38–0.99, p = 0.04), with a nonsignificant trend for reduced risk of nonfatal MI (HR: 0.74, 95% CI: 0.51–1.08, p = 0.12).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.